EPHX2 and stroke disorder: The latter may possess vasoactive properties by mediating eNOS activity47, and may also underly discrepancies observed in studies of cerebral inflammation following stroke between genetic deletion of sEH and pharmacological inhibition targeting the hydrolase domain specifically48.